logo

Andrew Kraft, MD

Andrew Kraft, MD

Hematology Charleston, SC

Professor of Medicine, Med University SC

Office Address

Office Map
  • 171 Ashley Ave
    MUSC Hollings Cancer Ctr
    Charleston, SC 29425
    Phone: (843) 792-1414

Summary

  • Dr. Andrew Kraft, MD is a board certified hematologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina. He is affiliated with Medical University of South Carolina and Ralph H. Johnson VA Medical Center.

Dr. Kraft's Clinical Specialties & Interests

  • Hematology: General Hematology

Dr. Kraft's Education & Medical Training

  • National Institutes of Health Clinical CenterNational Institutes of Health Clinical CenterFellowship, Medical Oncology
  • Mount Sinai School of MedicineMount Sinai School of MedicineResidency, Internal Medicine
  • U Penn Med SchoolPerelman School of Medicine at the University of PennsylvaniaMedical School

Dr. Kraft's Certifications & Licensure

  • SC State Medical LicenseSC State Medical LicenseActive through 2013
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Kraft's Awards, Honors, & Recognition

  • The American Society for Clinical InvestigationElected MemberThe American Society for Clinical Investigation, 1993

Dr. Kraft's Clinical Trials

Dr. Kraft's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Senior Leadership
    Senior LeadershipNational Cancer Institute
    2009 - 2012
  • Program Planning And Evaluation
    Program Planning And EvaluationNational Cancer Institute
    2009 - 2012
  • Medical University Of South Carolina - Cancer Center Support Grant
    Medical University Of South Carolina - Cancer Center Support GrantNational Cancer Institute
    2009 - 2012
  • Novel Inhibitors Of PIM Protein Kinases
    Novel Inhibitors Of PIM Protein KinasesNational Cancer Institute
    2009 - 2009
  • Developmental Funds
    Developmental FundsNational Cancer Institute
    2009 - 2012
  • Mechanisms By Which Proteasome Enhance Apoptosis
    Mechanisms By Which Proteasome Enhance ApoptosisNational Cancer Institute
    2004 - 2007
  • Mechanisms By Which Proteasome Enhance Apoptosis
    Mechanisms By Which Proteasome Enhance ApoptosisNational Cancer Institute
    2004 - 2004
  • Hollings Cancer Center Planning Grant
    Hollings Cancer Center Planning GrantNational Cancer Institute
    2003 - 2005
  • PIM 1 Protein Kinase As A  Target For Drug Discovery
    PIM 1 Protein Kinase As A Target For Drug DiscoveryNational Cancer Institute
    2003 - 2003
  • PIM 1 Protein Kinase As A  Target For Drug Discovery
    PIM 1 Protein Kinase As A Target For Drug DiscoveryNational Cancer Institute
    2002 - 2003
  • Developmental Therapeutics Programs
    Developmental Therapeutics ProgramsNational Cancer Institute
    2001 - 2002
  • Control Of Differentiation Of Human Promyelocytes
    Control Of Differentiation Of Human PromyelocytesNational Cancer Institute
    1999 - 2003
  • Phase II Trial Of Bryostatin 1 For Treatment Of Stage IV Breast Cancer
    Phase II Trial Of Bryostatin 1 For Treatment Of Stage IV Breast CancerNational Center For Research Resources
    1999 - 2002
  • Training In Pharmacology Of Antineoplastic Agents
    Training In Pharmacology Of Antineoplastic AgentsNational Cancer Institute
    1999 - 2003
  • Regulation Of Prostate Cancer Programmed Cell Death
    Regulation Of Prostate Cancer Programmed Cell DeathNational Cancer Institute
    1998 - 2001
  • Phase I/II RX Of Chronic Myelogenous Leukemia With Bryostatin 1
    Phase I/II RX Of Chronic Myelogenous Leukemia With Bryostatin 1National Center For Research Resources
    1998 - 2000
  • Bryostatin 1 Treatment For Patients With Metastatic Malignant Melanoma
    Bryostatin 1 Treatment For Patients With Metastatic Malignant MelanomaNational Center For Research Resources
    1998 - 2000
  • Mechanism Of Action Of GM-CSF
    Mechanism Of Action Of GM-CSFNational Institute Of Diabetes And Digestive And Kidney Diseases
    1997 - 2000
  • Bryostatin1 In Chronic Myelogenous Leukemia
    Bryostatin1 In Chronic Myelogenous LeukemiaNational Center For Research Resources
    1997 - 1997
  • Differentiation Therapy Of Chronic Myelogenous Leukemia
    Differentiation Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute
    1996 - 1996
  • Bryostatin 1 In Metastatic Malignant Melanoma
    Bryostatin 1 In Metastatic Malignant MelanomaNational Center For Research Resources
    1996 - 1997
  • Control Of Differentiation Of Promyelocytes
    Control Of Differentiation Of PromyelocytesNational Cancer Institute
    1996 - 1998
  • Bryostatin 1 Therapy Of Metastatic Melanoma
    Bryostatin 1 Therapy Of Metastatic MelanomaNational Cancer Institute
    1996 - 1996
  • Bryostatin 1 Therapy Of Metastatic Melanoma
    Bryostatin 1 Therapy Of Metastatic MelanomaNational Cancer Institute
    1995 - 1995
  • Differentiation Therapy Of Chronic Myelogenous Leukemia
    Differentiation Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute
    1995 - 1996
  • Control Of Differentiation Of Promyelocytes
    Control Of Differentiation Of PromyelocytesNational Cancer Institute
    1994 - 1996
  • Mechanism Of Action Of GM-CSF
    Mechanism Of Action Of GM-CSFNational Institute Of Diabetes And Digestive And Kidney Diseases
    1992 - 1995
  • The Role Of Protein Kinase C In Mediating N-RAS Protein
    The Role Of Protein Kinase C In Mediating N-RAS ProteinFogarty International Center
    1989 - 1989
  • Control Of Differentiation Of Human Promyelocytes
    Control Of Differentiation Of Human PromyelocytesNational Cancer Institute
    1986 - 1993

Hospital Affiliations

Insurance Accepted

  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Andrew Kraft, Dr. Andrew Kraft, MD, Dr. A Kraft, Dr. Andrew S Kraft

45 Colleague Invites!
Is this you? If so, register to see 45 messages.

Physicians, view Dr. Kraft's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV